- Home
- AVK vs MLAB Comparison
AVK vs MLAB Comparison
Compare AVK & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVK
- MLAB
- Stock Information
- Founded
- AVK 2003
- MLAB 1982
- Country
- AVK United States
- MLAB United States
- Employees
- AVK N/A
- MLAB N/A
- Industry
- AVK Trusts Except Educational Religious and Charitable
- MLAB Industrial Machinery/Components
- Sector
- AVK Finance
- MLAB Industrials
- Exchange
- AVK Nasdaq
- MLAB Nasdaq
- Market Cap
- AVK 523.6M
- MLAB 524.2M
- IPO Year
- AVK N/A
- MLAB N/A
- Fundamental
- Price
- AVK $11.89
- MLAB $98.61
- Analyst Decision
- AVK
- MLAB Hold
- Analyst Count
- AVK 0
- MLAB 2
- Target Price
- AVK N/A
- MLAB $130.00
- AVG Volume (30 Days)
- AVK 112.9K
- MLAB 144.2K
- Earning Date
- AVK 01-01-0001
- MLAB 08-04-2025
- Dividend Yield
- AVK 11.85%
- MLAB 0.65%
- EPS Growth
- AVK N/A
- MLAB N/A
- EPS
- AVK N/A
- MLAB N/A
- Revenue
- AVK N/A
- MLAB $240,978,000.00
- Revenue This Year
- AVK N/A
- MLAB $6.28
- Revenue Next Year
- AVK N/A
- MLAB $5.93
- P/E Ratio
- AVK N/A
- MLAB N/A
- Revenue Growth
- AVK N/A
- MLAB 11.47
- 52 Week Low
- AVK $9.24
- MLAB $83.68
- 52 Week High
- AVK $12.16
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- AVK 60.12
- MLAB 41.00
- Support Level
- AVK $11.56
- MLAB $87.80
- Resistance Level
- AVK $11.91
- MLAB $101.23
- Average True Range (ATR)
- AVK 0.12
- MLAB 3.91
- MACD
- AVK -0.02
- MLAB 0.38
- Stochastic Oscillator
- AVK 66.00
- MLAB 54.73
About AVK Advent Convertible and Income Fund
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.